How long does it take for Xalkori to work?
We can estimate from graphs plotting progression-free survival that Xalkori starts to work within approximately 2 months, but most trials report on how long Xalkori keeps a person’s cancer from getting worse, not how quickly it works. This is called progression-free survival.
- In one study of 343 people with ALK + NSCLC, the average progression-free survival was 10.9 months for the 172 patients treated with Xalkori, compared to 7 months for the 171 patients treated with chemotherapy.
- 74% of patients saw their tumors respond to Xalkori — compared to 45% of patients taking chemotherapy.
- 3 patients in the Xalkori group had all signs of cancer disappear (known as a complete response, but this does not mean that the cancer is cured) compared with 2 patients in the chemotherapy group.
- 125 of the 172 patients in the Xalkori group had a partial response, which means the spread of cancer lessened, or tumors shrank compared to 75 of the 171 patients in the chemotherapy group.
- However, no significant difference in overall survival has been noted between patients taking Xalkori and chemotherapy.
When Xalkori was used to treat patients with ROS1+ NSCLC that had spread to other parts of their body:
- 66% of people taking Xalkori saw their tumors respond or shrink
- One patient had all signs of cancer disappear (known as a complete response, but this does not mean that the cancer is cured)
- 32 of 50 patients had the spread of cancer lessened, or had tumors that shrank over 30% (known as a partial response)
- The length of time these partial and complete responses lasted before the tumors resumed growing or spreading was a median period of 18.3 months.
Note that in this trial Xalkori was not compared to another medication.
Regular scans by your cancer care team will reveal whether your tumor is responding to treatment with Xalkori. Keep taking Xalkori exactly as directed until your healthcare provider tells you to stop.
Xalkori) is an oral prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. Xalkori may also be used to treat anaplastic large cell lymphoma (ALCL), a type of blood cancer and unresectable, recurrent, or refractory ALK-positive inflammatory myofibroblastic tumors (IMT) in adults and children over the age of 1 year.
Related questions
References
- Xalkori (crizotinib). Updated 01/2022. Pfizer Laboratories Div Pfizer Inc. https://www.drugs.com/pro/xalkori.html
Read next
How to pronounce Xalkori?
Xalkori is pronounced “zal-KOR-ee”. Xalkori is the brand name product for crizotinib (pronounced “kriz OH ti nib”), the generic name of the drug. Continue reading
Do I need any blood tests while taking Xalkori?
Yes, you will need blood tests while you take Xalkori to help monitor your liver and kidney function, red and white blood cell counts, and in some cases, your electrolytes or blood sugar levels. Your doctor may also order a blood test to determine if you are pregnant. Continue reading
What cancers are treated with Xalkori?
Xalkori treats three types of cancers with genetic mutations: non-small cell lung cancer (NSCLC), anaplastic large cell lymphoma (ALCL), a type of blood cancer, and (ALK)-positive inflammatory myofibroblastic tumors (IMT). Continue reading
Related medical questions
- Is small cell or non-small cell lung cancer worse?
- Is non-small cell lung cancer hereditary?
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- How long does it take for Keytruda to work?
- Why give Taxol (Paxel) before carboplatin?
- What is the difference between Opdivo and Keytruda?
- Pembrolizumab vs. nivolumab: How do they compare?
- What is Paxel called in the USA?
- How effective is Lumakras, what's the survival rate?
- What is the difference between Mvasi and Avastin?
- How effective is Tabrecta?
- Are there cost-saving programs for Tecentriq?
- How does erlotinib work (mechanism of action)?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- How long can I take Gilotrif (afatinib) for?
- How effective is atezolizumab (Tecentriq)?
- Is atezolizumab (Tecentriq) a chemotherapy or immunotherapy drug?
- Will Tabrecta cure lung cancer?
- How long do you take Alecensa for?
- How does Retevmo work?
- Is Gilotrif (afatinib) a chemotherapy drug?
- Is Tabrecta a chemotherapy drug?
- How effective is Alecensa for ALK-positive NSCLC?
- What is the mechanism of action for Alecensa (alectinib)?
- Can Tarceva (erlotinib) cure lung cancer?
- How does pemetrexed work?
- How do Exkivity and Rybrevant compare for NSCLC?
Drug information
Related support groups
- Xalkori (7 questions, 28 members)
- Crizotinib (3 questions, 6 members)
- Non-Small Cell Lung Cancer (53 questions, 70 members)
- Lymphoma (17 questions, 45 members)